Prospective and Randomized Study to Evaluate the Effect of Everolimus in the Clinical and Intra-Cardiac Ecography Progression of Heart Graft Vascular Illness.

Trial Profile

Prospective and Randomized Study to Evaluate the Effect of Everolimus in the Clinical and Intra-Cardiac Ecography Progression of Heart Graft Vascular Illness.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Jul 2016

At a glance

  • Drugs Everolimus (Primary) ; Azathioprine; Ciclosporin; Corticosteroids; Mycophenolate mofetil; Tacrolimus
  • Indications Heart transplant rejection
  • Focus Therapeutic Use
  • Acronyms EVEROSTAT
  • Most Recent Events

    • 21 Apr 2012 Results presented at the 32nd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
    • 21 Apr 2012 IVUS results presented at the 32nd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
    • 21 Apr 2012 Results presented at the 32nd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top